<VariationArchive VariationID="12185" VariationName="NM_000198.4(HSD3B2):c.558dup (p.Thr187fs)" VariationType="Duplication" Accession="VCV000012185" Version="7" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-05-08" DateCreated="2016-04-08" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="27224" VariationID="12185">
      <GeneList>
        <Gene Symbol="HSD3B2" FullName="hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2" GeneID="3284" HGNC_ID="HGNC:5218" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="119414931" stop="119423034" display_start="119414931" display_stop="119423034" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="119957553" stop="119965661" display_start="119957553" display_stop="119965661" Strand="+" />
          </Location>
          <OMIM>613890</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000198.4(HSD3B2):c.558dup (p.Thr187fs)</Name>
      <CanonicalSPDI>NC_000001.11:119422056:CCC:CCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1p12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="119422056" stop="119422057" display_start="119422056" display_stop="119422057" variantLength="1" positionVCF="119422056" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="119964679" stop="119964680" display_start="119964679" display_stop="119964680" variantLength="1" positionVCF="119964679" referenceAlleleVCF="A" alternateAlleleVCF="AC" />
      </Location>
      <ProteinChange>T187fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.119964682dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.119964682dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.119422059dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.119422059dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_013349.1" sequenceAccession="NG_013349" sequenceVersion="1" change="g.12129dup">
            <Expression>NG_013349.1:g.12129dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000198.4" sequenceAccession="NM_000198" sequenceVersion="4" change="c.558dup" MANESelect="true">
            <Expression>NM_000198.4:c.558dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000189.1" sequenceAccession="NP_000189" sequenceVersion="1" change="p.Thr187fs">
            <Expression>NP_000189.1:p.Thr187fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001166120.2" sequenceAccession="NM_001166120" sequenceVersion="2" change="c.558dup">
            <Expression>NM_001166120.2:c.558dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001159592.1" sequenceAccession="NP_001159592" sequenceVersion="1" change="p.Thr187fs">
            <Expression>NP_001159592.1:p.Thr187fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="613890.0002" DB="OMIM" />
        <XRef Type="rs" ID="770815049" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000198.4(HSD3B2):c.558dup (p.Thr187fs) AND not provided" Accession="RCV001659693" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-03-08" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000198.4(HSD3B2):c.558dup (p.Thr187fs) AND 3 beta-Hydroxysteroid dehydrogenase deficiency" Accession="RCV000012968" Version="4">
        <ClassifiedConditionList TraitSetID="3299">
          <ClassifiedCondition DB="MedGen" ID="C0342471">3 beta-Hydroxysteroid dehydrogenase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-11-16" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-03-08" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2016-04-08" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1363812</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18252794</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3299" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="10967" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency</ElementValue>
                <XRef ID="MONDO:0008727" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE 2 DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="201810" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613890.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613890.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613890.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613890.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613890.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613890.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613890.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613890.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613890.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613890.0002" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">3 beta-Hydroxysteroid dehydrogenase deficiency</ElementValue>
                <XRef ID="3-Beta-Hydroxysteroid+Dehydrogenase+Deficiency/30" DB="Genetic Alliance" />
                <XRef ID="54470008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adrenal hyperplasia 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adrenal hyperplasia II</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">3b-hydroxysteroid dehydrogenase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">HSD3B deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">3-beta-HSD deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Type II 3-beta-hydroxysteroid dehydrogenase deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HSDB</ElementValue>
                <XRef Type="MIM" ID="201810" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9152" />
                <XRef ID="9152" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000320609" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000508723" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000555663" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000503060" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <XRef ID="90791" DB="Orphanet" />
              <XRef ID="C0342471" DB="MedGen" />
              <XRef ID="C538236" DB="MeSH" />
              <XRef ID="MONDO:0008727" DB="MONDO" />
              <XRef Type="MIM" ID="201810" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="33213" SubmissionDate="2016-04-06" DateLastUpdated="2016-04-08" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="613890.0002_ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE 2 DEFICIENCY" title="HSD3B2, 1-BP INS_ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE 2 DEFICIENCY" />
        <ClinVarAccession Accession="SCV000033213" DateUpdated="2016-04-08" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1992-07-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 34-year-old American male with CAH due to 3-beta-HSD deficiency (201810), Rheaume et al. (1992) found compound heterozygosity for the W171X mutation (613890.0001) and another frameshift mutation resulting from insertion of 1 bp, a C, between codons 186 and 187. They referred to the mutation as 186/insC/187. The parents were not consanguineous. One male sib with ambiguous genitalia and enlarged adrenal glands died of respiratory distress at 2 days of age. A female paternal first cousin with mildly ambiguous external genitalia died of diarrhea and vomiting at the age of 2 months. The autopsy showed hyperpigmented skin and markedly enlarged adrenal glands. Spermatogenesis was adequate in the index case since he had fathered 2 children; one died from congenital malformations and the other was found to be heterozygous for the 186/insC/187 mutation. The patient had marked loss of salt as well as hypospadias and gynecomastia at puberty. Hypospadias had been noted at the age of 1 month when the patient was found in a critically dehydrated condition. During the first 13 years of life until replacement therapy was initiated, the patient was admitted to hospital on 12 occasions with adrenal insufficiency with electrolyte imbalance.</Attribute>
              <Citation>
                <ID Source="PubMed">1363812</ID>
              </Citation>
              <XRef DB="OMIM" ID="201810" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HSD3B2" />
          </GeneList>
          <Name>HSD3B2, 1-BP INS</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="613890.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE 2 DEFICIENCY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4087016" SubmissionDate="2022-02-09" DateLastUpdated="2022-02-13" DateCreated="2022-02-13">
        <ClinVarSubmissionID localKey="NM_000198.4:c.558dup|3 beta hydroxysteroid dehydrogenase deficiency" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002094668" DateUpdated="2022-02-13" DateCreated="2022-02-13" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-11-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000198.4:c.558dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">3 beta hydroxysteroid dehydrogenase deficiency</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4260360" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4818211|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002247016" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18252794</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1363812</ID>
          </Citation>
          <Comment>This variant is also known as 186/insC/187. For these reasons, this variant has been classified as Pathogenic. This variant disrupts the C-terminal region of the HSD3B2 protein, which has been demonstrated to be critical for enzymatic activity (PMID: 18252794). While functional studies have not been performed to directly test the effect of this variant on HSD3B2 protein function, this suggests that disruption of this region of the protein is causative of disease. ClinVar contains an entry for this variant (Variation ID: 12185). This premature translational stop signal has been observed in individual(s) with 3-beta-hydroxysteroid dehydrogenase deficiency (PMID: 1363812). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs770815049, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Thr187Hisfs*17) in the HSD3B2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 186 amino acid(s) of the HSD3B2 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HSD3B2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.119964679_119964680insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3682000" SubmissionDate="2021-09-13" DateLastUpdated="2021-09-19" DateCreated="2021-09-19">
        <ClinVarSubmissionID localKey="NM_000198.4:c.558dup|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001880910" DateUpdated="2021-09-19" DateCreated="2021-09-19" Type="SCV" Version="1" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">1363812</ID>
          </Citation>
          <Comment>This variant is expected to result in the loss of a functional protein. The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant has been identified in at least one individual with clinical features associated with this gene.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000198.4:c.558dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10229685</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4087016" TraitType="Disease" MappingType="Name" MappingValue="3 beta hydroxysteroid dehydrogenase deficiency" MappingRef="Preferred">
        <MedGen CUI="C0342471" Name="3 beta-Hydroxysteroid dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="33213" TraitType="Disease" MappingType="Name" MappingValue="ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE 2 DEFICIENCY" MappingRef="Preferred">
        <MedGen CUI="C0342471" Name="3 beta-Hydroxysteroid dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4260360" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3682000" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

